ZYDONE (hydrocodone bitartrate and acetaminophen tablets), for oral administration, contain hydrocodone bitartrate and acetaminophen in the following.
Genitourinary System: Ureteral spasm, spasm of vesical sphincters and urinary retention have been reported with opiates.
The total daily dosage should not exceed eight tablets.
ZYDONE (hydrocodone bitartrate and acetaminophen tablets) is indicated for the relief of moderate to moderay severe pain.
The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
Acetaminophen is excreted in breast milk in small amounts, but the significance of its effects on nursing infants is not known.
The recalled bottles are supposed to contain tablets made up of 10 milligrams of hydrocodone and 500 milligrams of acetaminophen. But they.
Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.
Dec. 26, 2012 -- More lots of the combination painkiller hydrocodone - acetaminophen are being recalled by Mylan Institutional. The new alert follows a nationwide recall of 101 lots of the drugs issued by Qualitest Pharmaceuticals that occurred earlier this month.
Having trouble identifying your pills?
If you have the affected lots you can contact Mylan Customer Service at.
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and.
Page Last Updated: 09/24/2012 Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
RECOMMENDATION : Pharmacists and wholesalers are asked to check their inventories for lots 519406A or 521759A segregate any material from the lots, and to contact GENCO Pharmaceutical Services at for instructions on product return.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
ISSUE : Watson Laboratories, Inc.
Watson Laboratories, Inc initiated a voluntary nationwide recall for two lots of hydrocodone bitartrate and acetaminophen tablets, 10 mg/500 mg.
Watson Laboratories, Inc initiated a voluntary nationwide recall for two lots of hydrocodone bitartrate and acetaminophen tablets, 10 mg/500 mg, due to the possibility that some tablets may contain more than the indicated amount of active ingredient. No reports of injuries related to the recalled product have been received to date. Watson cautions that “unintentional ingestion of excessive amounts of acetaminophen may potentially result in an adverse event, including liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day.” The company also warns that “unintentional ingestion of excessive amounts of hydrocodone may result in an adverse event” including sedation or respiratory depression.
Drug information and side-effects for NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg).
MediLexicon International Ltd Bexhill-on-Sea, UK MediLexicon International Ltd.
The Norco Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg) have been approved for the treatment of moderate pain. NORCO is the highest single tablet dose of Hydrocodone Bitartrate with the lowest level of Acetaminophen of all 10 mg Hydrocodone combination products indicated for the relief of moderate to moderay severe pain.